摘要
目的分析产前检查免疫检验项目的临床应用价值。方法方便选取2016年1月—2017年12月医院收治的孕妇100名作为观察对象,随机分为观察组与对照组。对照组产前接受常规检查,而观察组在对照组的基础上加入免疫检查。分析观察组产妇免疫检查结果以及两组产妇高危妊娠情况。结果观察组50名产妇中,未发现抗HIV阳性者,仅有1例(2.0%)梅毒抗体阳性、2例(4.0%)乙肝抗体阳性、1例(2.0%)丙肝抗体阳性,并根据检查结果,给予对症干预措施。观察组与对照组的高危妊娠率为4.0%和16.0%,两组间比较差异有统计学意义(χ2=6.524,P=0.000)。结论产前免疫检查能够及时发现孕妇有无高危妊娠因素,并及时进行干预,能够降低高危妊娠率,从而保障母婴健康。
Objective This paper tries to analyze the clinical application value of the prenatal inspection immunoassay project. Methods Convenient selection the pregnant women admitted to 100 hospitals from January 2016 to December 2017 were randomly selected into the observation group and the control group. The control group received routine examination before delivery, while the observation group added immunological tests based on the control group. The results of maternal immunological examination in the observation group and maternal high-risk pregnancies were analyzed. Results In the observation group, no HIV-positive women were found in 50 women. Only 1 patient（2.0%） was positive for syphilis antibodies, 2 points（4.0%） were positive for hepatitis B antibodies, and 1 patient（2.0%） was positive for hepatitis C antibodies, and according to the test results, symptomatic interventions were given. The high-risk pregnancy rates in the observation group and the control group were 4.0% and 16.0%, and the difference between the two groups was statistically significant（χ^2=6.524, P=0.000）. Conclusion Prenatal immunization can promptly detect whether pregnant women have high-risk pregnancy factors, and timely intervention, can reduce the high-risk pregnancy rate, thus ensuring maternal and child health.
作者
费秀云
FEI Xiu-yun(Department of Clinical Laboratory,Maternal and Child Health Planning and Child Care Service Center,Rizhao,Shandong Province,276800 China)
出处
《中外医疗》
2018年第14期23-25,共3页
China & Foreign Medical Treatment
关键词
产前检查
免疫检验
临床应用
Prenatal examination
Immunoassay
Clinical application
